| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/03/2004 | US6770797 Inducing prolonged in vivo gene expression in a mammal for inhibiting alzheimer's disease associated neuronal cell death |
| 08/03/2004 | US6770784 Reducing appetite |
| 08/03/2004 | US6770778 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters |
| 08/03/2004 | US6770743 Genetic engineered drug |
| 08/03/2004 | US6770676 Dicarboxylic acid derivatives |
| 08/03/2004 | US6770669 Amidine derivatives, preparation and use thereof as medicines |
| 08/03/2004 | US6770667 N-((imidazolyl)-phenyl)-fluorene-1-carboxamide derivatives; 5-hydroxytryptamine (5-ht) antagonists; psychological, nervous system, eating, brain and sleep disorders |
| 08/03/2004 | US6770661 Aryl substituted pyridines and their use |
| 08/03/2004 | US6770657 Compounds |
| 08/03/2004 | US6770656 Amine derivatives for the treatment of apoptosis |
| 08/03/2004 | US6770654 Indole derivatives and use thereof in medicines |
| 08/03/2004 | US6770651 A2B adenosine receptor antagonists |
| 08/03/2004 | US6770643 Inhibit protein kinases |
| 08/03/2004 | US6770642 For use in treatment of cns disorders such as anxiety, depression, epilepsy, obsessive compulsive disorder, attention deficit disorder, migraine, cognitive memory enhancement, alzheimer's disease |
| 08/03/2004 | US6770637 Substituted 4-phenyl-pyridine compounds with activity as antagonists of neurokinin 1 receptors |
| 08/03/2004 | US6770626 Amino acid sequence from certain regions of tissue growth factor-beta super family serine-threonine kinase receptors |
| 08/03/2004 | US6770449 Methods of assaying receptor activity and constructs useful in such methods |
| 08/03/2004 | CA2294716C Method for drying anhydrous paroxetine hydrochloride |
| 08/03/2004 | CA2121065C External anti-inflammatory and analgesic plaster preparation |
| 07/29/2004 | WO2004063221A1 Metastin derivative and use thereof |
| 07/29/2004 | WO2004063202A1 Fused furan compound |
| 07/29/2004 | WO2004063201A1 Therapeutic agent for schizophrenia |
| 07/29/2004 | WO2004063196A1 1,2,4-triazin-3-yl-hydrazine or 5h-1,2,4-triazino’5,6-b!indol-3-yl-hydrazine compounds as inhibitors of bace useful in the treatment of alzheimer |
| 07/29/2004 | WO2004063193A1 4-{`3-(sulfonylamino) phenyl! `1-(cyclymethyl) piperidin-4-ylidene! methyl} benazmide derivatives as delta opioid receptor ligands for the treatment of pain, anxiety and functional gastrointestinal disorder |
| 07/29/2004 | WO2004063177A1 Benzoxazole derivatives and their use as adenosine receptor ligands |
| 07/29/2004 | WO2004063174A1 Process for the preparation of 1,2-dichloroethane free crystals of zonisamide and the highly pure crystals of zonisamide |
| 07/29/2004 | WO2004063167A1 Blood-brain barrier disruption inhibitors |
| 07/29/2004 | WO2004063161A1 Saturated and unsaturated heteroarylcycloalkylmethyl amines as anti-depressants |
| 07/29/2004 | WO2004063152A2 Lansoprazole formulations and related processes and methods |
| 07/29/2004 | WO2004062686A2 Therapeutic use of modulators of notch |
| 07/29/2004 | WO2004062675A1 Method of modulating il-6 |
| 07/29/2004 | WO2004062665A1 Heteroaryl- substituted pyrrolo` 2, 3- b! pyridine derivatives as crf receptor antagonists |
| 07/29/2004 | WO2004062662A1 Aminoindazole derivatives and use thereof as kinase inhibitors |
| 07/29/2004 | WO2004062655A1 Alpha-aminoamide derivatives useful as antimigraine agents |
| 07/29/2004 | WO2004062652A1 Prevention and treatment of alzheimer's disease |
| 07/29/2004 | WO2004062625A2 Macrocyclic beta-secretase inhibitors for treatment of alzheimer's disease |
| 07/29/2004 | WO2004062616A2 Method of treating cognitive decline due to sleep deprivation and stress |
| 07/29/2004 | WO2004062592A2 2-o sulfatase compositions and related methods |
| 07/29/2004 | WO2004062564A2 Sedative non-benzodiazepine formulations |
| 07/29/2004 | WO2004062561A2 Pharmaceutical compositions comprising fentanyl for intranasal delivery |
| 07/29/2004 | WO2004062554A2 Enhancement of dopaminergic neuron generation and survital |
| 07/29/2004 | WO2004050629A3 The use of 4-phenyl substituted tetrahydroisoquinolines in the treatment of pain, migraine and urinary incontinence |
| 07/29/2004 | WO2004050086A8 Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics |
| 07/29/2004 | WO2004047819A3 Composition and its use for treating neuropathic sensory loss |
| 07/29/2004 | WO2004045533A3 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 07/29/2004 | WO2004041304A3 Pain relief agents |
| 07/29/2004 | WO2004037173A3 Method for treating erectile dysfunction and increasing libido in men |
| 07/29/2004 | WO2004035536A3 Azo compounds for type i phototherapy |
| 07/29/2004 | WO2004014913A3 Derivatives of 2-trifluormethyl-6-aminopurine as phosphodiesterase 4 inhibitors |
| 07/29/2004 | WO2004010972A3 Pellicle-resistant gelatin capsule |
| 07/29/2004 | WO2003099783A3 Tropane compounds |
| 07/29/2004 | WO2003094861A3 Bis-benzimidazoles and related compounds as potassium channel modulators |
| 07/29/2004 | WO2003086317A3 Protein a compositions and methods of use |
| 07/29/2004 | WO2003082262A3 Compositions of venlafaxine base |
| 07/29/2004 | WO2003068803A3 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 07/29/2004 | WO2003040107A8 Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity |
| 07/29/2004 | WO2002067957A8 Use of defibrinated blood for manufacture of a hemoglobin-based oxygen carrier |
| 07/29/2004 | US20040147754 Novel process |
| 07/29/2004 | US20040147752 Carbazole derivatives for the treatment of NPY related diseases |
| 07/29/2004 | US20040147745 Novel compounds and compositions as protease inhibitors |
| 07/29/2004 | US20040147741 Heptadecapeptide nociceptin opioid receptor modulators; pain relievers; synthesis |
| 07/29/2004 | US20040147724 for diagnosis/treatment of cancer, myeloproliferative disorders, angiogenesis, obesity, osteoporosis, non-insulin dependent diabetes, lipid metabolism disorder, hypercalcemia, hypercholestrolemia; genetic engineering |
| 07/29/2004 | US20040147614 Serotonin receptor antagonist; administering reboxetine; psychological disorders |
| 07/29/2004 | US20040147613 Synergistic mixture; blocking neurotransmitters; dopamine receptors; haloperidol and (meth)amphetamine |
| 07/29/2004 | US20040147610 Aging resistance; anticancer agents; neurodegradation disease;amyotropic lateral sclerosis; Alzheimer's disease |
| 07/29/2004 | US20040147607 Storage stability |
| 07/29/2004 | US20040147600 Mixture of drug with insulin; antidiabetic agents |
| 07/29/2004 | US20040147583 Anxiolytic agents; Alzheimer's disease |
| 07/29/2004 | US20040147577 Heterocyclic compounds |
| 07/29/2004 | US20040147573 Metalloproteinase inhibitors |
| 07/29/2004 | US20040147570 Substituted 1 and 2-naphthol mannich bases |
| 07/29/2004 | US20040147562 Controlling cell gene expression; moderate cell proliferation; anticancer agents; antiinflammatory agents; cardiovascular disorders; autoimmune disease |
| 07/29/2004 | US20040147558 Synthesis of 3-amino-thalidomide and its enantiomers |
| 07/29/2004 | US20040147556 Analgesics; anxiolytuic agents; gastrointestinal disorders |
| 07/29/2004 | US20040147553 Efficiency; side effect reduction; antiarthriutic agents; autoimmune diseases |
| 07/29/2004 | US20040147551 Competitive binding to estrogen; prevent mnopause syndrome ; anxiolytic agents; antidepressants; benign prostatic hyperplasia; anticancer agents; inflammatory bowel disorders; antiarthritic agents |
| 07/29/2004 | US20040147546 Heterocyclic compounds |
| 07/29/2004 | US20040147538 Fused heterocyclic compounds |
| 07/29/2004 | US20040147531 Neurodegradation diseases; alzheimer's disease; down's syndrome; antidiabetic agents |
| 07/29/2004 | US20040147528 Crystal structure; antidepressants; anxiolytic agents; eating disorders; bipolar disorders; Alzheimer's disease; sleep disorders; |
| 07/29/2004 | US20040147526 Analgesics; anxiolytic agents; gastrointestinal disorders |
| 07/29/2004 | US20040147525 Antiinflammatory agents; analgesics; antiarthritic agents |
| 07/29/2004 | US20040147520 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists |
| 07/29/2004 | US20040147519 Sulfonylquinoxalone acetamide derivatives as bradykinin antagonists |
| 07/29/2004 | US20040147517 Imidazolophthalazine derivatives as ligands for gabaa receptors |
| 07/29/2004 | US20040147512 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/29/2004 | US20040147506 Muscarinic acetylcholine receptor antagonist; Parkinson's disease; dystonia; analgesics; irritable bowel syndrome |
| 07/29/2004 | US20040147505 Neurodegradative diseases; antiinflammatory agents; analgesics; drug abuse |
| 07/29/2004 | US20040147504 Therapy for neuropathic pain; antiinflammatory agents |
| 07/29/2004 | US20040147495 Sapogenin derivatives, their synthesis and use, and methods based upon their use |
| 07/29/2004 | US20040147490 Immunosuppressants |
| 07/29/2004 | US20040147485 Antiinflammatory agents; antiischemic agents; antiarthritic agents; antihistamines; multiple sclerosis; Alzheimer's disease; Huntington's disease; parkinson's disease; antiepileptic agents; headaches |
| 07/29/2004 | US20040147482 Cubane derivatives as metabotropic glutamate receptor antagonists and process for their preparation |
| 07/29/2004 | US20040147438 For therapy of neuroblastoma |
| 07/29/2004 | US20040147434 Use of enzyme inhibitors of the dipeptidypeptidase iv (ec3.3.14.5) in addition to the aminopeptidase n (ec 3.4.11.2), individually or in a combination thereof, and pharmaceutical preparations thereof for the prevention and/or therapy of ischaemia-caused acute and chronic neurodegenerative process and illnesses, for example |
| 07/29/2004 | US20040146967 Novel g protein-coupled receptor protein and dna thereof |
| 07/29/2004 | US20040146953 Assay |
| 07/29/2004 | US20040146946 used to study oxidative stress-related disorders and diseases and drug screening treatments for Alzheimer's disease |
| 07/29/2004 | US20040146945 used to study oxidative stress-related disorders and diseases and drug screening treatments for Alzheimer's disease |
| 07/29/2004 | US20040146935 Disease associated gene |